← Back to guidelines
Hematology19 papers

Wiskott-Aldrich syndrome

Last edited: 4/14/2026

Overview

Wiskott-Aldrich syndrome (WAS) is an X-linked primary immunodeficiency characterized by eczema, thrombocytopenia, recurrent infections, and increased susceptibility to malignancies 14.

Diagnosis

  • Clinical Features: Recurrent infections, eczema, and thrombocytopenia 14.
  • Laboratory Findings: Abnormalities in T-cell function, reduced antibody responses, and low platelet count 14.
  • Molecular Testing: Confirmation through molecular screening of WAS gene mutations 3.
  • Management

  • First-Line Treatment: Immunoglobulin replacement therapy to manage infections and immune dysfunction 14.
  • Adjunctive Treatments:
  • - Platelet Transfusion: For severe thrombocytopenia 1. - Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): Curative option for severe cases 2.

    Special Populations

  • Pediatrics: Early HSCT (median age 30 months) improves outcomes 2.
  • Comorbidities: Severe refractory thrombocytopenia (SRT) early in life is a significant risk factor for poor prognosis 1.
  • Key Recommendations

  • Early HSCT for Severe Cases: Consider allogeneic HSCT in severe WAS cases to achieve curative outcomes (Evidence: Moderate) 2.
  • Monitor Platelet Count Closely: Regular monitoring of platelet counts is crucial as severe thrombocytopenia predicts poor prognosis (Evidence: Strong) 1.
  • Initiate Immunoglobulin Therapy: Start immunoglobulin replacement therapy to manage recurrent infections and immune deficiencies (Evidence: Expert opinion) 14.
  • References

    1 Notarangelo LD. In Wiskott-Aldrich syndrome, platelet count matters. Blood 2013. link 2 Muñoz A, Olivé T, Martinez A, Bureo E, Maldonado MS, Diaz de Heredia C et al.. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON). Pediatric hematology and oncology 2007. link 3 Lawson SE, Thompson L, Williams MD. Wiskott Aldrich syndrome presenting as congenital thrombocytopenia. Clinical and laboratory haematology 1999. link 4 Dubiel A, Szczerbinski T, Kurtyka Z, Kowalczyk D. Wiskott-Aldrich syndrome. A case report. Clinical pediatrics 1990. link

    Original source

    1. [1]
    2. [2]
      Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).Muñoz A, Olivé T, Martinez A, Bureo E, Maldonado MS, Diaz de Heredia C et al. Pediatric hematology and oncology (2007)
    3. [3]
      Wiskott Aldrich syndrome presenting as congenital thrombocytopenia.Lawson SE, Thompson L, Williams MD Clinical and laboratory haematology (1999)
    4. [4]
      Wiskott-Aldrich syndrome. A case report.Dubiel A, Szczerbinski T, Kurtyka Z, Kowalczyk D Clinical pediatrics (1990)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG